Published January 15, 2019 | Version v2
Report Open

Further Investigation of the Reduction of HTT Protein through Chemical Inhibition

Authors/Creators

  • 1. Structural Genomics Consortium, University of Toronto

Description

Funding acknowledgement The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.

Files

Files (375.1 kB)

Name Size Download all
md5:2dfe7e182207aae66af2058944f37607
36.3 kB Download
md5:afb0dcf6bfab85e7daa130a718a9fccd
225.3 kB Download
md5:e1002664d62827fc838763f43e223457
113.4 kB Download